|
Packaging Defect Involved in Voluntary Drug Recall
Boehringer Ingelheim Pharmaceuticals, Inc. announced Nov. 7 that it is conducting a nationwide voluntary recall of a single manufacturing lot of Pradaxa (dabigatran etexilate mesylate).
Healthcare Packaging |
Register Now
Archives